Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:28:32.088Z.
Calculation as of: 2026-10-06T18:28:32.088Z.
Quote observation: 2026-10-06T18:25:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0deb7c30adcc78f114172cbc577a9cc7a44fb527f6444d978a27313071d44bdc
EARNINGS YIELD
N/A
Market Cap
$16.55M
Earnings Yield
N/A
TTM Avg
119.21%
3Y Avg
119.21%
5Y Avg
80.35%
Market Cap
$17.14M
Earnings Yield
N/A
TTM Avg
16.05%
3Y Avg
16.05%
5Y Avg
16.05%
Market Cap
$15.65M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TScan Therapeutics, Inc. (TCRX) | $16.58M | N/A | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.55M | N/A | 119.21% | 119.21% | 80.35% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.70M | N/A | N/A | N/A | N/A |
| Palatin Technologies, Inc. (PTN)vs › | $17.14M | N/A | 16.05% | 16.05% | 16.05% |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | N/A | N/A | N/A | N/A |
| Lipocine Inc. (LPCN)vs › | $17.11M | N/A | 0.00% | 5.85% | 5.85% |
| BioCardia, Inc. (BCDA)vs › | $15.78M | N/A | 4.38% | 3.50% | 25.86% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.65M | N/A | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $18.05M | N/A | 2.31% | 2.31% | 2.31% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.36M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
